ZYN, the popular brand of flavored nicotine pouches, recently earned FDA authorization for reducing smoking, but some questions linger. Experts explain the efficacy and potential health risks of nicot

In the final days of the Biden administration, the Food and Drug Administration (FDA) has taken a significant step toward reducing nicotine levels

If conventional cigarettes are banned, many consumers would turn to the black market rather than settle for legal very low nicotine cigarettes.

Robert F. Kennedy Jr. is publicly advocating for health as he tries to get confirmed as secretary of health and human services — yet using a highly addictive product while doing so.

The FDA is proposing a limit on the amount of nicotine in cigarettes and certain other combustible tobacco products to reduce their addictive properties.

After reviewing the scientific evidence, the agency has decided 20 ZYN nicotine pouch products can legally be sold in the US.

FDA authorizes Zyn nicotine pouches, citing public health benefits for adult smokers, despite concerns over flavored products' appeal to teens.

On January 15, the U.S. Food and Drug Administration (FDA) issued a proposed rule that would set a maximum nicotine level in combusted cigarettes

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches. The pouches, which are placed between the lip and gum, are tobacco-free but contain nicotine. They come in different strengths and a variety of flavors such as citrus, coffee, peppermint and berry.

The US FDA has issued a proposed rule to lower the level of nicotine in cigarettes and certain other combustible tobacco products.

On January 17, the FDA authorized ZYNs for sale, claiming their benefit to tobacco users outweighed their risk to the public.

She noted the FDA previously proposed a rule to ban menthol cigarettes, which has stalled since its 2022 announcement. But if the nicotine in cigarettes is standardized, the ripple effects could ...